LloydsPharmacy
Former UK community-pharmacy chain supplying prescription medicines, over-the-counter products, health services, and online prescription fulfilment.
Last updated August 21, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
LloydsPharmacy was a major British community-pharmacy brand whose stores supplied prescription medicines, over-the-counter treatments, health and personal-care products, and pharmacy advice. Its roots went back to 1973, when Allen Lloyd bought a pharmacy in Polesworth, Warwickshire, and began building a larger retail pharmacy business. The Lloyds Pharmacy name assumed its modern network identity after Celesio combined Lloyds Chemist with the Hills Pharmacy network owned by its UK subsidiary AAH Pharmaceuticals in 1997–1998. For much of its later life, the brand operated as part of increasingly large healthcare and pharmaceutical distribution groups. Celesio acquired Lloyds in 1997, and Celesio itself was acquired by the American healthcare company McKesson in 2014. LloydsPharmacy therefore combined a highly visible high-street presence with links to pharmaceutical wholesaling and healthcare supply. In 2015 it expanded substantially by acquiring the pharmacies located inside Sainsbury’s supermarkets. The transaction added 281 outlets and approximately 2,500 employees, taking the chain to around 1,800 branches and more than 19,000 employees at the time. The outlets were subsequently rebranded under LloydsPharmacy. The company’s services included dispensing NHS and private prescriptions, selling non-prescription medicines and healthcare products, and providing services associated with community pharmacy. It also developed digital channels. The online prescription service LloydsDirect grew sharply during the 2020–2021 period, although the wider company experienced a fall in turnover over the same period. In 2019 Lloyds acquired Echo, an online prescription-fulfilment business, strengthening its digital-prescription capabilities. The chain later entered a period of retrenchment. In 2017 it announced plans to close or sell 190 English shops and increase its use of digital channels. It subsequently decided to leave Sainsbury’s in-store pharmacy locations, announcing in January 2023 that the withdrawal would take place during that year. LloydsDirect was sold to Pharmacy2U in October 2023. In the same year, the high-street and community pharmacy estate was sold to new owners, either individually or in regional groups. The transfer covered 1,054 branches and was reported to preserve approximately 6,500 branch jobs, but it also ended LloydsPharmacy’s operation as a unified national pharmacy chain. The wider McKesson UK business was acquired by Aurelius Group in 2022 and later rebranded as Hallo Healthcare Group. After the branch disposals, Lloyds Pharmacy Ltd was no longer part of Hallo Healthcare Group or operating the former pharmacy network. The Lloyds Pharmacy name was acquired for continued online use by Expert Health, but the original operating company entered voluntary liquidation in late 2023 or early 2024. The company’s final years were marked by store disposals, digital-asset divestment, ownership change, and liquidation rather than continued expansion.
History
LloydsPharmacy developed from a single independent pharmacy acquired by Allen Lloyd in Polesworth, Warwickshire, in 1973. The business expanded through the creation and acquisition of additional pharmacies and became known as Lloyds Chemist. Its later national identity was shaped by corporate consolidation: Celesio AG purchased the business in 1997 and combined it with the Hills Pharmacy network operated by Celesio’s UK subsidiary, AAH Pharmaceuticals. The merged network adopted the Lloyds Pharmacy name from January 1998 and operated roughly 1,300 pharmacies. The brand became part of a larger international healthcare structure when McKesson acquired Celesio in 2014. LloydsPharmacy remained a prominent UK community-pharmacy operator, dispensing prescriptions and selling medicines, health products, and personal-care goods. Its scale increased substantially in 2015 when it agreed to buy 281 pharmacies inside Sainsbury’s supermarkets for £125 million. The deal transferred approximately 2,500 Sainsbury’s pharmacy employees to Lloyds. Following regulatory review and approval, the pharmacies were rebranded, and the chain reached approximately 1,800 locations with more than 19,000 employees. The company also faced regulatory and commercial controversy. In 2013, press reports discussed allegations of inflated NHS medicine pricing and possible payments connected with the supply of medicines. Separately, the Office of Fair Trading fined Quantum Pharmaceutical in a case involving an alleged agreement with Lloyds concerning the division of part of the care-home prescription market. In Ireland, Lloyds agreed to a €12 million settlement with the Health Service Executive in 2016 over phased dispensing for medical-card patients. These matters formed part of the regulatory background to the company’s later history, although the available reference material does not establish that every allegation resulted in a finding against Lloyds itself. Lloyds began repositioning its business as the economics of high-street pharmacy became more difficult. In 2017 it announced the planned closure or sale of 190 English shops and an increased emphasis on digital channels. It bought Echo, an online prescription-fulfilment business, in 2019. The LloydsDirect online service subsequently grew strongly during 2020–2021, while total company turnover declined. Branch numbers fell from 1,427 in 2020 to 1,351 in March 2021. In April 2022, Aurelius Group acquired McKesson’s UK businesses, including LloydsPharmacy. The UK operation was later rebranded as Hallo Healthcare Group. Lloyds subsequently announced its withdrawal from all Sainsbury’s in-store pharmacies, and in October 2023 sold LloydsDirect to Pharmacy2U. In November 2023, the 1,054 remaining high-street and community branches were sold to new owners in individual or regional transactions. This preserved many local services and branch jobs but ended LloydsPharmacy’s operation as a single national chain. The Lloyds Pharmacy name continued to have an online presence under rights acquired by Expert Health, while the original Lloyds Pharmacy Ltd later entered voluntary liquidation. The company was reported in January 2024 to have debts of £293 million, including £228 million owed to its former parent Admenta UK.
- 2024
Liquidation reported
[1]Lloyds Pharmacy Ltd was reported to have entered liquidation with substantial debts.
- 2023
Digital and branch disposals
[1]Lloyds announced its exit from Sainsbury’s in-store pharmacies, sold LloydsDirect to Pharmacy2U, and sold its remaining 1,054 branches to new owners.
- 2022
Aurelius acquires McKesson UK businesses
[1]Aurelius Group acquired McKesson’s UK operations, including LloydsPharmacy.
- 2019
Echo acquisition
[1]Lloyds acquired Echo to expand its online prescription-fulfilment capabilities.
- 2015
Sainsbury’s pharmacy acquisition
[1]Lloyds agreed to acquire 281 pharmacies operated inside Sainsbury’s supermarkets for £125 million.
- 2014
McKesson acquires Celesio
[1]LloydsPharmacy became part of McKesson following McKesson’s acquisition of Celesio.
- 1998
Merged network adopts Lloyds Pharmacy name
[1]The merged operation began trading under the Lloyds Pharmacy name and comprised approximately 1,300 pharmacies.
- 1997
Celesio acquires Lloyds
[1]Celesio AG purchased the Lloyds business and combined it with its UK Hills Pharmacy network.
- 1973
Allen Lloyd acquires the first pharmacy
[1]Allen Lloyd bought a pharmacy in Polesworth, Warwickshire, establishing the business that later developed into LloydsPharmacy.
Products and positioning
Community pharmacy and accessible health services
Pharmacy service
Prescription dispensing
Prescription dispensing was the core service of LloydsPharmacy’s community branches. Stores supplied NHS and private prescriptions, supported repeat-medication collection, and provided pharmacist-facing advice within local communities. The exact service mix varied by branch and by the regulatory arrangements in the relevant UK nation.
Healthcare retail
Over-the-counter medicines
LloydsPharmacy stores sold non-prescription medicines and treatments for common conditions, alongside pharmacist guidance. The range formed part of the chain’s retail health offer and complemented its prescription-dispensing business.
Consumer health
Health and personal-care products
The chain offered a broad selection of health, wellness, personal-care, and related pharmacy products. These categories helped position its branches as accessible healthcare retailers rather than prescription-only dispensaries.
Online pharmacy
LloydsDirect
LloydsDirect was LloydsPharmacy’s online prescription service. It supported digital prescription fulfilment and grew substantially during 2020–2021. The service was sold to Pharmacy2U in October 2023.
Online prescription fulfilment · 2019
Echo
Echo was an online prescription-fulfilment business acquired by Lloyds in 2019. Its capabilities contributed to LloydsPharmacy’s effort to develop digital alternatives to conventional branch-based prescription collection.
Controversies
2016
Irish phased-dispensing settlement
Lloyds agreed to a €12 million settlement with Ireland’s Health Service Executive over phased dispensing arrangements for medical-card holders.
2013
Allegations concerning NHS medicine pricing
Press reports alleged that prices for more than 20,000 medicines may have been inflated and referred to Lloyds in connection with an unusually high NHS charge for cod-liver-oil products. NHS Protect was reported to have investigated the matter.
2013
Care-home prescription market cartel case
Quantum Pharmaceutical received an Office of Fair Trading fine exceeding £380,000 in a case concerning an alleged arrangement with Lloyds to divide part of the prescription-drug market for care homes.
Brand decisions
2023
Exit Sainsbury’s pharmacies and sell LloydsDirectStrategyBackground
Lloyds was reducing its physical footprint while separating or monetising digital operations.
Action taken
It announced a withdrawal from Sainsbury’s in-store pharmacies and sold LloydsDirect to Pharmacy2U.
Aftermath
The moves reduced the scope of the LloydsPharmacy operating platform before the remaining branches were sold to new owners.
2023
Sell remaining community-pharmacy branchesM&ABackground
The parent’s UK healthcare business was reorganising the LloydsPharmacy estate.
Action taken
The 1,054 remaining high-street and community branches were sold to new owners in individual or regional transactions.
Aftermath
The unified LloydsPharmacy chain ceased operating, although branch services continued under new ownership and the name retained an online presence.
2019
Acquire EchoM&ABackground
Lloyds wanted to strengthen its online prescription-fulfilment capability.
Action taken
It acquired Echo for an undisclosed amount.
Aftermath
Echo became part of the group’s digital prescription strategy, which later included LloydsDirect.
2017
Reduce the physical-store estateStrategyBackground
The company was adjusting to pressure on the economics of high-street pharmacy and the growth of digital channels.
Action taken
Lloyds announced plans to close or sell 190 English shops and increase its use of digital services.
Aftermath
The decision foreshadowed the later reduction and sale of the branch network.
2015
Acquire Sainsbury’s supermarket pharmaciesM&ABackground
Lloyds sought to expand its UK pharmacy footprint through Sainsbury’s in-store locations.
Action taken
It agreed to buy 281 pharmacies for £125 million and rebrand the outlets after regulatory approval.
Aftermath
The acquisition expanded the network to approximately 1,800 branches and more than 19,000 employees before later retrenchment.
Acquisition price. £125 million (2015)
Recent events
- 2024
Lloyds Pharmacy Ltd enters liquidation[1]
Bankruptcy
The company was reported to have entered liquidation with debts of £293 million, including £228 million owed to former parent Admenta UK.
- 2023
LloydsPharmacy to withdraw from Sainsbury’s in-store pharmacies[1]
Other
Lloyds announced that it would exit all Sainsbury’s in-store pharmacy locations during 2023.
- 2023
LloydsDirect sold to Pharmacy2U[1]
M&A
The company sold its online prescription service LloydsDirect to rival Pharmacy2U for an undisclosed amount.
- 2023
LloydsPharmacy branch network sold to new owners[1]
M&A
The former McKesson UK business confirmed the sale of 1,054 LloydsPharmacy high-street and community branches to new owners, either individually or in regional groups. The transaction was reported to preserve approximately 6,500 branch jobs.
- 2022
McKesson UK businesses sold to Aurelius Group[1]
M&A · Leadership change
Aurelius Group acquired McKesson’s UK businesses, including LloydsPharmacy, wholesaler AAH, and a travel-health service.
- 2019
LloydsPharmacy acquires online prescription business Echo[1]
M&A · Product launch
Lloyds acquired Echo, a UK online prescription-fulfilment business, for an undisclosed amount.
- 2017
LloydsPharmacy announces store closures and digital expansion[1]
Other
The company announced plans to close or sell 190 of its 1,600 English shops while increasing its reliance on digital channels.
- 2015
LloydsPharmacy acquires Sainsbury’s supermarket pharmacies[1]
M&A · Regulation
Lloyds announced an agreement to acquire all 281 pharmacies located in Sainsbury’s supermarkets for £125 million. The transaction was referred to the Competition and Markets Authority and later approved, after which the outlets were rebranded.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/lloyds-pharmacy · Editorial policy · How profiles are compiled